Substitution of care within benign gynecology during the COVID-19 pandemic in the Netherlands

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 05160482240003

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2023
    2025
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    dr. prof WJK Hehenkamp
  • Research Location

    N/A
  • Lead Research Institution

    Amsterdam UMC Locatie VUmc
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

During the COVID-19 pandemic, less surgery was performed than before (or after). Elective care surrounding benign diseases has been particularly hard hit; after all, priority was given to acute and oncological surgery. In benign gynecology, surgical elective care has virtually come to a standstill. It is obvious that alternative treatments have been offered to these patients during the COVID-19 period. Purpose and method With this research we will find out which care was provided instead of operations and how satisfied patients and caregivers were with this. With this information we can draw up a protocol for which care should be offered and how in a new period of absolute scarcity. But even in the case of relative scarcity, one can learn from substituted care: if patients are equally satisfied with non-operative treatment, operations may be performed less frequently. This can contribute to lower healthcare costs and relieve the burden on staff.